As per reports, technology giant Microsoft Corp (MSFT) is in talks to launch a version of its search engine Bing using the artificial intelligence used behind chatbot ChatGP, launched by OpenAI. The company is expecting to launch the new feature before the end of March, hoping to challenge Alphabet-owned search engine Google.
In 2019, Microsoft backed an offering of $1 billion in funding, for San Francisco-based artificial intelligence company OpenAI forming a multi-year partnership to develop artificial intelligence supercomputing technologies on Microsoft’s Azure cloud computing service. OpenAI and Microsoft declined to comment on the matter.
Redmond, Washington-based American multinational technology company Microsoft (MSFT) develops, manufactures, licenses supports, and sells computer software, consumer electronics, personal computers, and related services. To learn more about Microsoft (MSFT) and to track their progress please visit the Vista Partners Coverage Page.
DID YOU KNOW?
Fertility rates have hit a record low in the United States. The latest US government fertility statistics come from 2019, and they estimate there were 58.2 births year per 1,000 women of childbearing age (defined by the CDC as women between ages 15 and 44).
If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.